Search Results for "massachusetts"

Nidhi Lucky Handa: Consumer-Friendly Cannabis Products Under a Multistate Lifestyle Brand

LEUNE is a California-based cannabis company that has expanded into Arizona and Maine since its launch. The lifestyle company was founded by Nidhi Lucky Handa, a former celebrity talent manager, and a luxury brand communications expert. LEUNE brands and sells packaged cannabis flower, one-time-use vape pens, and rosin gummies.

In this written interview, Nidhi breaks down the reasoning behind LEUNE’s branding and market expansion, how they source their products, the quality control that goes into sourcing and branding the company’s consumer packaged goods across multiple states, and more.

Scroll on to read the full interview!


Ganjapreneur: What have you enjoyed about starting a business? Alternatively, what are the hard parts of entrepreneurship that can be glossed over?

Nidhi Lucky Handa: Great question – much of the time founder life creates tunnel vision and laser focus on moving forward, so it’s nice to pause and reflect on the highs as well as the…challenges!

The parts I love are so easy to see in the rear view – building a team, a culture, getting the big ideas from paper to production, celebrating the smallest of victories – but the reality is, I’m learning now that the best parts are actually in the process, in the now. I feel so immensely grateful to have a business in this dynamic industry and to have the opportunity to tell the stories that are important to me with a team I adore and learn from everyday.

The harder parts are the ones you’d expect – making choices that are in the best interest of the company even when they’re at the expense of a part of the vision. It’s a constant pivoting exercise running a business in an emerging industry and that means (sometimes) letting go of the passion projects or putting them on ice for a later time.

When you couldn’t find adult-use products catered to women on dispensary shelves, you identified a gap in the market and decided to create LEUNE. How do you believe LEUNE has filled this gap, and how does its branding and marketing advance this concept?

I was (and still am) less interested in gender and more interested in building something for a consumer (like me and my peer group) who is excited about legal weed, but isn’t/wasn’t being spoken to. I wanted to build something that was aesthetic and stylish, well-priced and high on quality – that’s where LEUNE was born.

We’ve been thoughtful about everything from consumer arc to buying habits. We’ve paid close attention to the consumers who want to initially just dip their toe in the pond but quickly convert to regular customers – we’ve listened closely to what makes folks stick around and what makes them leave.

I’ve put a strong emphasis on the creative spirit at LEUNE because that’s what resonates with me as a consumer. Our campaigns are ethereal, beautiful and relatable all at the same time.

What branding components signal to the ideal cannabis consumer that LEUNE products are for them? How else does the brand engage the consumer in the retail store?

That’s a good question- I believe that consumers who are drawn to LEUNE branding are attracted to the clean, modern, color-blocked aesthetic and simple overall architecture of the brand.

What attracted LEUNE to Maine as you expanded into new markets?

Maine is close to my heart as a Massachusetts native. I spent many a summer holiday in Portland growing up. The food and craft culture are all in such perfect alignment with who we are as a brand – small, unique, happily in our own skin. We were thrilled when the stars aligned and the opportunity presented itself. I love shopping the dispensaries in Maine and soaking in the passion for the plant that the local market clearly hones in on.

Did LEUNE complete any market research before releasing products in Maine? What research tools or resources were helpful during the expansion?

Yes, of course! We do so for every market. We look carefully at existing brand presence, product assortment, price points and quality. In order to build out a plan and product assortment that fits well for the market in question we do extensive research. In terms of tools, we talk to experts in the market, visit stores and go through retail menus – it’s the most accurate and up to date way to get this kind of data – albeit very time consuming.

What is Honestly Grown, and what moved the team to create the publication?

Honestly Grown is LEUNE’s quarterly lifestyle magazine. It focuses on raising the bar surrounding the conversation on cannabis. With activism and social justice at its forefront, Honestly Grown aims to bring awareness to the reader through interviews, anecdotal submissions, art and education.

We were inspired to create a magazine because we wanted to use our creative resources to highlight the importance of social justice in cannabis, such a s restorative justice for those still currently incarcerated for nonviolent cannabis crimes. We are also aiming to destigmatize conversations around cannabis and promote conversations that normalize the plant in every way.

Why did the brand choose to expand its product offerings, and what dictated that the new product would be a gummy candy?

From inception it was always clear to me that LEUNE would be vertical agnostic – even at launch with four SKUs, it was two all-in-one vapes and two pre-rolls.

We are proudly a consumer-first brand – and in an industry that is so young and constantly evolving, we want to listen to the consumer and understand what, why, where and how often they want to consume. In order to do that, we have to give them choice and pay attention to the evolving use-case of different form factors.

As for the gummies – those took the most R+D, time and iteration to get right, and I couldn’t be prouder. Rosin, gluten free, vegan, taste GREAT…they check all the boxes of a discerning consumer.

Who is your manufacturing partner in California? How do you oversee quality control using an offsite manufacturing facility?

We’ve worked with over a dozen facilities across the state to ensure LEUNE products stay on the shelf! We’ve learned so much about the importance of super buttoned up, specific SOPs and rigorous QA/QC check-ins over the years. It’s essential that brands stay vigilant and particular about the consistency of the products to ensure that customers have a great experience again and again.

How do you manage quality control as you’ve expanded into new markets? Can a consumer expect the same quality pre-roll from a California and Arizona dispensary?

As a brand this is of utmost concern and care. We vet our partners through-and-through.

Does LEUNE use sales teams, software, or a combination of the two to reach its retail partners?

It looks a little different in every market. Here in CA, LEUNE products are distributed and sold by a full service distributor. With that relationship we have access to a robust team of professionals throughout the state who can reach all corners of California.

When a new store puts in an order, does the brand educate retail staff before the products hit shelves?
ABSOLUTELY! Education (at every level) is the most important part of sales in my opinion! Ensuring that the budtenders are able to speak to the UVP of the brand is essential to strong sell through and retention.

What types of cannabis products do you think will gain popularity among California consumers in the coming year, and why?

​ROSIN GUMMIES! Consumers are starting to learn the benefits of rosin in edibles – no more distillate hangover for starters. It’s a game changer and once you try a better quality product (like LEUNE Gem Drops) it’s impossible to go back.

Do you have advice for entrepreneurs interested in building a consumer-focused brand?

The cliche is true – be authentic, find a problem and fix it, know what your UVP is!


Thanks again, Nidhi, for answering our questions! Our readers can visit LEUNE.co to learn more.

End


NECANN’s New Consumption-Friendly High Life Style Show Coming Oct 7-9

NECANN’s High Lifestyle Show will be a first-of-its kind in Massachusetts. The three-day event will be a 30,000 sq ft indoor and outdoor gathering of cannabis brands, retailers, distributors, growers, artists, performers, and consumers converging at a private resort hotel. The event will feature both a conference and festival setting with exhibitors, vendors, concerts, comedy, education, celebrities, socializing and networking.

As a business event, one of our goals is to have businesses, entrepreneurs and brands to be able to meet the distributors, retailers and consumers in an entertaining, safe environment. Retail distributors can promote their products and retail locations in order to compete to attract new customers. Artists can find new fans. Craft growers and brands can showcase their products (in legally acceptable quantities) to curators, dispensaries, and delivery licensees. Making the connection and showing products, knowledge, and skills will allow next-generation and legacy growers to find new paths to success.

As a LifeStyle event, we will be showcasing all aspects of the canna-inspired culture including health, wellness, music, art, clothing, literature, food, cultivation, supplies, medical, educational and ancillary aspects including cannabis weddings and travel.

There will be multiple forms of entertainment all weekend, with live music headlined by: The Wailers, Jon Butcher Axis, Roots of Creation, Brett Wilson, Mikaela Davis, Barrence Whitfield, Walter Sickert & The Army of Broken Toys, Tsunami of Sound, Justine’s Black Threads and more.

Comedy highlights include Dan Hall & The Weed Game Show, plus LIVE Stand-up starring Matt Barry, Mona Forgione, Ian Stuart, Josh Day, all weekend long.

There will also be celebrity signings, artists, and educational seminars on various aspects of the cannabis industry.

Access to the property Oct. 7-9 will be limited to 21+ aged ticket holders, and cannabis activities allowed will be anything legal by Massachusetts laws including outdoor consumption (the event is 21+). Attendees will be allowed to carry a quantity that is legally allowed in Mass, and consume combustible cannabis on property outdoors. No THC products will be sold on premises, although CBD and non-infused products will be.

“The concept for this event has been years in the making, following the craft wine and craft beer movements, both regulated in a similar manner as cannabis,” said event promoter Gary Sohmers. “That model where brands are allowed (by law) to allow people to “taste” their products to build brand loyalty and let people try something prior to buying it, allowed smaller businesses to succeed in stores, bars, and restaurants because of consumer demand. We hope that this consumption-friendly event will be a step in the direction of safe and legal tasting events in Massachusetts”.

For more information email: marc@necann.com or GarySohmers@gmail.com

 

End


Ascend Wellness CEO Arrested for Domestic Battery

Ascend Wellness Holdings, Inc. CEO and Founder Abner Kurtin, 55, was arrested last week on misdemeanor battery charges against his domestic partner, The Deep Dive reports. Kurtin was eventually released on a $1,500 bond and issued a stay-away order allowing pre-trial conditional victim contact.

The legal definition of battery, according to the Legal Information Institute from Cornell Law School, constitutes the “unlawful application of force directly or indirectly upon another person or their personal belongings, causing bodily injury or offensive contact.”

The Miami-Dade Clerk said Kurtin’s arraignment was scheduled for September 30, according to the report.

Ascend Wellness — a multi-state cannabis operator (MSO) with assets in six U.S. states including Illinois, Michigan, Massachusetts, New Jersey, Ohio, and Pennsylvania — issued a statement following Kurtin’s arrest:

“The company is aware of allegations against CEO, Chairman, and Founder Abner Kurtin regarding a domestic-related misdemeanor. The independent members of the company’s Board of Directors, through its Compensation and Corporate Governance Committee, are conducting an investigation of the matter with the assistance of independent legal counsel, Goodwin Procter, LLP.” — Ascend Wellness statement via press release

“While the company cannot comment on an active investigation, it is treating this matter with the utmost seriousness and will continue to evaluate appropriate steps as more information becomes available,” the statement continued. “The independent members of the board are keenly attuned to the company, its shareholders, and employees, and the management team is focused on ensuring AWH continues to operate effectively during this time.”

End


What Does the Future of Cannabis Networking Look Like?

Editor’s note: This editorial was contributed by Dan Serard, the Director Of Business Development & Strategic Partnerships for Cannabis Creative, a Massachusetts-based award-winning digital marketing agency specializing in cannabis and CBD.

When California first opened up the floodgates of cannabis by legalizing medical marijuana in 1996, the industry was apprehensive and cold. As other states followed suit, dispensaries remained sterile, clinical places with bland products that resembled a pharmaceutical prescription.

As we put those days in the rearview mirror, so too are brands and professionals that adhere to that image. Instead, we’re seeing sophisticated brands and innovative marketing teams changing the landscape of the cannabis industry.

So why haven’t we done the same for cannabis networking?

Traditional cannabis events like trade shows have helped bring legitimacy to the industry over time, but at the end of the day, the real changemakers in cannabis are looking to create meaningful business relationships that go beyond the surface-level interactions typical of a large business conference. Particularly in a post-pandemic era, we need to reimagine the cannabis networking experience. Instead of buttoned-up elements like expensive booths and corporate attire, we need to curate intentional, memorable moments with one another.

The Evolution of the Trade Show

There are quite a few aspects of a large event that can be inconvenient. The number of attendees at conventional trade shows is often overwhelming. Exhibition floors are brimming with booths and teams walking through. Cannabis (usually) cannot be sampled out, brands have their sales pitch on repeat all day, and most interactions are brief and superficial at best. You can be intentional about who you connect with and how you spend your time, but there are no guarantees that you’ll be able to have a fruitful conversation with so many distractions.

Seth Worby, the CEO and Co-Founder of Cannabis Creative Group and Founder of the TeeHC Open, and a frequent attendee at trade shows, adds that “They’re tiring. You’re on your feet for eight hours straight. They’re expensive: food, hotels, travel, etc. A show can cost a small team upwards of $10K.”

While trade shows have been an amazing tool in the industry for a long time, the truth is that post-pandemic trade shows are struggling to maintain popularity. In the long run, brand-centered, fun experiences will win out over corporate programming. This will include events like industry competitions, brand-hosted pop-ups and experiences, and interactive cannabis events. After all, this is an industry that is heavily based on the senses.

The Future of Cannabis Networking Events

After being cooped up inside for almost two years, people are eager – but also apprehensive – to get back to in-person events. At the same time, everything from consumer behavior to family dynamics and company culture has shifted dramatically since March 2020.

The result is a need for more interactive, meaningful events to take place.

When it comes to networking in such a highly creative and competitive industry, the key is not to know everyone, but rather to build valuable and meaningful relationships with the right people. Therefore, cannabis professionals are not interested in cold pitching people who are not interested in their brand. Rather, they want to meet warm leads and connect with partners that are genuinely excited to work together.

As we conceive what post-pandemic cannabis networking events might look like, it begs the question of who is most fit to host and facilitate these types of relationships. The most obvious answer is those who have their ear to the ground: ancillary businesses. From cannabis marketing agencies to brand consultants, ancillary cannabis businesses hear a wide range of needs from all types of players in the industry.

Whether you’re a dispensary or a CBD brand or anything in between, it is likely that you’re working with an ancillary business to help grow yours. What better way to pave the way for the future of cannabis networking than with these creative professionals? With all this in mind, there are key elements that define the future of cannabis networking events. These events will – and should – include:

  • Interactive elements for attendees to engage in
  • Brand activation opportunities
  • Creative networking activities and spaces
  • Community-building programming
  • Flexible and inclusive cannabis consumption policies
  • Hosts that facilitate lead introductions

Post-Pandemic Networking is Here to Stay

The last few years have changed the landscape of our society – permanently. As much as we wanted those lockdowns to be a temporary fluke, the pandemic has created change that is here to stay. Consumers no longer want to be overtly sold to. They want to shop from brands they are loyal to, brands that align with their values, and brands that understand the value of a meaningful relationship.

This shift impacts major players and small businesses in the industry alike. As cannabis professionals seek out more engaging, fun, and meaningful networking events, we expect that it will not be a trend that comes and goes. Instead, we’ll see these features expand to other industries and become essential to the success of future networking events.

End


MLB Hall of Famer Launches Cannabis Brand

Major League Baseball (MLB) Hall of Famer and Boston Red Sox legend David Ortiz is launching a cannabis line which is expected to be available in Massachusetts dispensaries this month, Boston.com reports. Ortiz, who was known during his career as Big Papi, is the first MLB Hall of Famer to launch a cannabis brand. 

The venture is called Papi Cannabis and is a partnership with Rev Brands. 

In a statement, Ortiz said he began using cannabis following his professional baseball career to help manage the pain from the years of playing and to help balance the stress of his schedule. 

“Once I embraced the flow of the flower everything changed. Cannabis has helped me relax, sleep better, manage stress and heal physically after a lifetime of playing ball, and I look forward to sharing Papi Cannabis and my personal journey to help people understand its benefits.” — Ortiz, in a statement, via Boston.com 

Sweet Sluggers, pre-rolled blunts, will be the first product in the Papi Cannabis line. They feature “Ortiz’s choice” cannabis strains like Black Mamba #7, Lava Cake #7, Motorbreath #15, and Bootylicious #4, according to the release. The blunts are wrapped in traditional, non-tobacco wrappers. Ortiz indicated he worked with his daughter on the packaging design.  

“I personally prefer pre-rolled blunts, and these ones are special to me because I was able to work with my daughter Alexandra on the colorful artwork for the packaging,” he said in the statement. 

The company plans next to launch vape cartridges, a salve, and an infused chocolate made from fair trade chocolate sourced from the Dominican Republic, where Ortiz was born.  

End


Senators Send Letter to Biden Urging Him to Deschedule Cannabis

Six U.S. senators last week sent a letter to President Joe Biden (D) urging him to use his executive authority to deschedule cannabis and issue pardons to all individuals convicted of non-violent cannabis crimes. 

The signatories include Democratic Massachusetts Sens. Elizabeth Warren and Ed Markey, New York Sen. Kirsten Gillibrand (D), New Jersey Sen. Corey Booker (D), Oregon Sen. Ron Wyden (D), and independent Vermont Sen. Bernie Sanders. The group had previously sent a letter asking the Biden Administration – namely the Department of Justice – to deschedule cannabis in October and in the recent letter noted that the response to their inquiry took more than six months and was a half-page that noted the Department of Health and Human Services (HHS) had determined “cannabis has not been proven in scientific studies to be a safe and effective treatment for any disease or condition.” In the recent letter, the senators say that response “ignores the ability of the DOJ and Drug Enforcement Administration to begin the descsheduling process and act independently of an HHS determination.” 

The senators said the administration has still not responded to a November letter they sent to the president asking him “to pardon all individuals convicted of non-violent cannabis offenses, whether formerly or currently incarcerated.” In April, Biden pardoned nine individuals convicted of non-violent cannabis crimes, but the senators say “much more has to be done to address the racist and harmful legacy of cannabis policies on Black and Brown communities.”  

“The legacy of the war on drugs is pervasive,” the senators write. “It is estimated that over 40,000 individuals are still incarcerated for cannabis-related offenses.” 

The letter calls out the administration for failing “to coordinate a timely review of its cannabis policy” which the senators say “is harming thousands of Americans, slowing research, and depriving Americans of their ability to use marijuana for medical or other purposes.” 

All of the letter signatories represent states that have legalized cannabis for adults.  

End


New York Times Publishes Heavily Biased Article on Teen Cannabis Use

The New York Times on June 23 published an article highlighting the adverse experience of a teenager using cannabis concentrates – it’s the second time this year the outlet has taken a fear-mongering approach to its cannabis coverage.

At Cannabias, we’ve already broken down the problem with this coverage, namely, teenagers shouldn’t be using cannabis in the first place unless they are registered patients. For starters, 14-years-old is too young to be using cannabis. Highlighting teens using cannabis and using that story as a vehicle for the possible harms of consumption is coverage bias. For every ‘teen uses cannabis, has adverse effects’ story, there are hundreds of competing stories of cannabis – used properly – helping kids with seizure disorders, Crohn’s disease, and with cancer treatment; however, the New York Times seems hellbent on highlighting the negative outcomes (‘if it bleeds, it leads,’ after all).

Adjective and adverbial bias are apparent throughout: graph four describes “euphoria (morphing) into something more disturbing.” Cannabis made the subject of the story (again a teenager) “feel more anxious or sad” or passing out in the shower. Well, yeah, her brain is still developing, of course she’s going to feel adverse effects, she’s a teenager, as teens we all feel bouts of anxiety and sadness. Also, (and I think we’ve crossed this bridge before) where are her parents when she’s passed out in the shower? The following graph also shows adjective and adverbial bias by describing the concentrates as “typically about 90% THC.” Do those products exist? They sure do but, even in legal markets are increasingly tough to find. They’re referred to as “platinum” in some circles and I’ve yet to see them in vape cartridge form, as the story suggests. To be fair, I’ve only made legal purchases in Michigan, Canada, Maine, Massachusetts, and on tribal land in New York and while I have seen concentrates near 90% THC, I’ve not seen them actually hit 90% on paper, but I digress.

Okay, so the New York Times article makes the claim that “nearly everyone” the subject knew was using these high-test concentrates, but doesn’t provide evidence and doesn’t interview anyone else which is an example of tone bias or even quality bias.

The author then migrates to what appears to be the trend du jour for anti-cannabis coverage recently: cannabinoid hyperemesis syndrome (CHS), the condition that causes some (very few) cannabis consumers to vomit uncontrollably. This is, again, coverage bias as the condition is relatively rare with the only study attempting to figure out the rate finding about 155 of 2,127 patients meeting the criteria for CHS or a “phenomenon similar.”

The author cites studies throughout; however, one study on an issue does not equate to “studies” (omission bias) and everyone in the industry that I’ve ever spoken to believes we need more studies to back up those of the National Institutes of Health (NIH) and other government-backed organizations and studies. (The problem with that is federal prohibition, which makes that near impossible.)

The author also includes one quote from the subject’s father but did she not ask the question, “where were you when she was 14 vaping (alleged) 90% THC?” I mean, that, for me, would be a key issue in this narrative.

The article is also plagued with photographic bias: images of brightly-colored vape pens, a blonde girl using a branded vape, what appear to be Nerds (maybe the cannabis copycat version, it’s unclear) a “liquid live resin in a girl’s bedroom” – each one utilized to invoke the ‘that could be my child’ fear. The whole article is designed to stoke fear and the accompanying images are meant to drive that point home.

The article, like many I’ve covered that focuses on youth cannabis use, fails to even tiptoe into the issue of personal responsibility. ‘It’s the drug’s fault!’ they scream, but where are the parents? Where are they even obtaining these products? I can tell you, in every single retail dispensary I have ever been to, I get ID’d (and I have grey hair in my beard); in Massachusetts and Canada I get ID’d twice. If these teenagers are getting these products from dealers, that is a topic worthy of investigation and, again, nearly every cannabis industry operator I have spoken to has explained the lengths they go through to subvert diversion and doesn’t want to see their products in the hands of teens. Also, where are these kids getting the money for these products? Platinum (the 90% concentrate) is $100 for a half gram at almost every retailer I’ve ever been to and while that may not be the case in more mature markets, these are the high-level questions the media should be focused on, rather than the kid who smoked too much cannabis and got sick.

As a youth, I drank often to the point of getting alcohol poisoning like an idiot, where was the New York Times then? As an instructor at a college, I see kids come in who drank too much the night before in a 9:30 am class – where is the New York Times to write 4,000 words about that? It’s coverage bias plain and simple. It’s gatekeeping bias. It’s irresponsible.

Remedy: The reporter could have tried to get to the bottom of how these kids are accessing such potent products, why the parents didn’t intervene, they could have interviewed the alleged other teenagers who are using these products, could have better explained the rarity of CHS, or that 90% THC products are not really that prevalent in legal markets. This article is high on conjecture, low on investigation, follows one subject, interviews too few experts, and relies on the old “what about the children” argument to demonize cannabis.

Cannabis should be used responsibly – by adults and in low doses or small doses of concentrates (just like alcohol) and the reporting around it should also be responsible. According to NIH statistics, 5,000 young people die annually as a result of underage drinking but you’d be hard-pressed to find the Times writing about any of those.

End


Medical Cannabis Now Tax Free in New Jersey

Medical cannabis is now tax-free in New Jersey as provisions of the Jake Honig Compassionate Use Medical Cannabis Act implementing the tax cut took effect on July 1, NJ Biz reports. Prior to the final reductions, medical cannabis was the only medicine in the state subject to tax.  

Before July 1, 2020, medical cannabis in New Jersey was subject to a 6.625% tax, which is the state’s sales tax. Jake’s Law reduced that tax to 4% on July 1, 2020; 2% on July 1, 2021; and fully reduced the tax on July 1, 2022. 

Honig was a 7-year-old New Jersey boy with brain cancer whose symptoms were partially relieved by medical cannabis. He passed away in 2018 following a five-year cancer battle and state lawmakers passed the bill with his namesake on July 2, 2019.  

Adult-use cannabis taxes are not affected by Jake’s Law.  

Several other states, including Alaska, Delaware, Louisiana, Maryland, Massachusetts, Minnesota, New Hampshire, Oregon, Pennsylvania, Utah, Vermont, and Washington do not levy sales taxes on medical cannabis sales. Medical cannabis sales in Arizona, Arkansas, California, Colorado, Connecticut, Florida, Hawaii, Illinois, Iowa, Maine, Michigan, Mississippi, Missouri, Montana, Nevada, New York, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Dakota, Washington, D.C., and West Virginia are either subject to state taxes, excise taxes – or a combination of both – or businesses are required to pay gross receipts taxes and that cost could be passed on to patients. 

End


Stone Road: Embracing Authenticity In Cannabis, From Cultivation to Marketing

Many cannabis farms are struggling to make ends meet, especially in California where there is a wholesale flower glut. Despite these challenges, the multi-state cannabis brand Stone Road has seen significant expansion in the last two years. Stone Road’s flagship farm is in Nevada City, California and its products are also available in Oklahoma and Massachusetts.

Founder Lex Corwin spoke with Ganjapreneur about his vision for the brand, the setbacks and triumphs along the way, and how they’ve achieved regular growth in the historically fickle cannabis market. The thread tying the brand together from its natural farming practices to its unconventionally beautiful marketing assets is authenticity: everything aligns with Corwin’s core values and taste. “We’re trying to go weird because I am weird and a lot of my friends are weird and we like weird and beautiful and interesting things. And so that’s honestly the pillar of how we approach branding,” he said.

The young entrepreneur first learned about cannabis farming from hippy elders in Northern Oregon and took that knowledge home to Southern California. Those first teachers are why the brand uses living soil and seeks out natural pesticides like ladybugs and predator mites rather than spraying OMRI-certified pesticides.

Stone Road purchased its Nevada City property out of foreclosure in 2016. Over the next year, they removed almost 10 tons of garbage and rehabilitated the remote 57-acre lot. As they rehabbed the land, they installed an artesian well, bringing the farm completely off-grid. Stone Road hires employees who are local to the area and teach them farming skills in the same way that Corwin got his start growing cannabis.

Currently, Stone Road cultivates greenhouse-grown cannabis on one acre and leaves the majority of their land natural and untamed. This is ideal for the local flora and fauna but can bring more pests. The team is realistic about growing in the woods and always seeks out the natural answer to their problems rather than disrupting their local wildlife. Corwin brought in a veteran farmer to consult on their pest issue in the first few runs and their advice was to look to nature for any potential pest’s natural predators. They use beneficial insects, fungi, amoebas, and more in the soil to keep natural predators at bay. They also spray plants down with water in the morning and at dusk to reduce native colonies of aphids or local mites.

The farm focuses on ultra-small batches, constantly providing new flavors rather than sticking to the same thing. Corwin travels to small farms to seek out specialty strains grown with Stone Road’s principles, which is one way that they procure strains with unique and notable aromatic profiles. They currently have 8 SKUs and within those, they may have 3-12 flavors at any time. Corwin explained, “Cannabis is an agricultural crop, a crop that hasn’t had a great deal of standardization, and people are always going to want something new. So for us, it made the most sense that we constantly push out new batches. We don’t have one product that is just our product that we keep making, it is constantly rotating.”

Stone Road’s flavors continue to change but the quality is always consistent. Corwin is passionate about only offering products that he would want to use himself. While in the early days, supply chain complications with partnering manufacturers forced Stone Road to push through product that wasn’t fully up to their standards in order to stay afloat, Corwin now only partners with like-minded people to sell Stone Road products outside of California. These partners include Solar Cannabis Co. in Massachusetts and other living soil, natural farmers in Oklahoma. The brand plans to expand soon into New York and other new states in the coming year. When Corwin is looking for like-minded partners, he’s not just seeking out natural farmers who grow clean cannabis, he’s also calling in fellow weirdos.

Stone Road’s branding centers around empowerment, being yourself, and celebrating every facet of beauty. “To us, we don’t do the sleazy thing of selling sex to sell, it’s more that we use a lot of sex-positive people that believe that the human body is beautiful in all its forms and iterations and we’re there to complement that. We want to show cool, beautiful — sometimes unconventionally beautiful — people consuming our products and enjoying them. Ultimately, that was born out of trying to show the cannabis industry as it actually is, because it is unbelievably diverse,” Corwin said. “We have a small contingent of very, very, very loyal followers. And I don’t know if it’s that they see themselves in the branding or, you know, as a proudly gay person having other gay and queer people supporting the brand because obviously, we gotta stick together!”

Stone Road doesn’t spend money on advertising but instead provides a platform for people who consume their products. A lot of models featured in their marketing reached out organically or the team noticed them and dug their look. Weird, interesting, and beautiful is Corwin’s preferred aesthetic and this is presented through the artistic, thought-provoking imagery that represents the brand. He is excited about their entry into the New York marketplace, where new team members are introducing a new wave of creativity for the brand.

Every step Corwin takes alongside Stone Road is sure-footed in authenticity and this may be the secret sauce that led to 700% growth in 2020, further growth in 2021, and record-breaking sales months in 2022. He doesn’t bother himself with comparing their products to other brands or bending their marketing to the trends; instead, the team creates products and a message that they would want to receive. “The thesis is working and we just need to create better and better products, and more consistently,” said Corwin, who also doesn’t pay himself a salary, choosing instead to put profits into paying fair wages and crafting great products.

In the coming year, they plan to eliminate petroleum-based plastic from their supply chain, which will be accomplished once they fully change their joint 5-packs packaging to air-tight, child-proof tins. They are also launching a gummy product in partnership with Sundae School made with all-natural fruit juices and sugars. The edible will be Sundae Schools’ first gummy made with solventless hash. Eventually, Corwin hopes to have a product in every form factor, and looks forward to further expanding across the US.

To learn more about Stone road visit https://stoneroad.org/.

End


Fox News’ Laura Ingraham Blames Mass Shootings on Cannabis Normalization

Last week, Fox News host Laura Ingraham suggested that the rising use and cultural acceptance of cannabis is an attributing factor to the trend of mass shootings in the U.S. As my colleague astutely noted in Ganjapreneur’s coverage of Ingraham’s statement, “the modern mass shooting crisis … outdates the modern cannabis legalization movement by nearly five decades,” pointing out that that the gun violence crisis has its roots the 1966 massacre at the University of Texas.

This is far from the first time Ingraham has used her Fox News platform to demonize cannabis and those who consume it. On New Year’s Day 2019, reacting to a CNN segment featuring reporter Randi Kaye on a canna-bus in Denver, Colorado, Ingraham tweeted, “We’ll see how this all works out for our country. More potheads, increase in cases of schizophrenia, psychosis, more impaired driving…as #BigWeed makes billions.”

Ingraham also has a habit of calling cannabis consumers “weedies” (adjective bias) and retweeting opinions from cannabis opponents. Ingraham has also described cannabis consumers as “dopes smoking dope” and that cannabis is “wrecking the minds of young people,” according to a Cheat Sheet report.

A study published last year in the Journal of the American Academy of Psychiatry and the Law Online examining previous studies linking violent behavior and cannabis found a “strictly correlational link” between cannabis use and violence – not causational – the strength of which “varies depending on the population (e.g., populations with severe and persistent mental illness versus the general population).”

A study published last month in Scientific Reports suggests cannabis consumers are more empathetic, moral, and prosocial than non-consumers. Hardly seems like the personality types to commit mass shootings.

And, to be fair, it’s not just Ingraham making these claims. A quick Google search finds opinion articles making this claim, right-wing news organizations, and gun control (and anti-legalization) groups. These same groups have also claimed that violent video games and prescription drugs are to blame.

Yes, studies – including this often-cited one from British and Dutch researchers – have found that daily cannabis use increased the likelihood of violence for people with psychotic disorders such as schizophrenia, but that is linked to those already diagnosed with the disorder.

Katherine Newman, author of “Rampage: The Social Roots of School Shootings” and University of Massachusetts System Chancellor for Academic Programs, called the claims that cannabis use is a key factor in mass school shootings “absolute nonsense” in an interview with Politifact.

“There is no link whatsoever between marijuana and extreme violence,” she said.

For the book, Newman, a sociologist, interviewed more than 200 interviews with residents of towns where these mass casualty events occurred.

In 2019, more than 100 scholars published a letter refuting the claims of school-shooter and cannabis links, calling the “science” behind the assertions “junk.”

“While associations between marijuana use and mental illness have been established, research suggests that the association is complex and mediated by multiple factors other than marijuana, including genetics,” the letter states. “Similarly, associations between individual characteristics and violence are multi-factorial. Thus, establishing marijuana as a causal link to violence at the individual level is both theoretically and empirically problematic.”

Education Week tracks school shootings – there have been 10 so far this year – and of those four occurred in states where cannabis is legal for adult use (one occurred in Washington, D.C. where adult-use is permitted but there is no legal access.) The Uvalde shooting, the nation’s deadliest thus far, happened in Texas, which has among the most stringent cannabis laws in the nation. So even if legalization increased cannabis access for youth, which it doesn’t, this type of violence has occurred this year mostly in states where cannabis remains illegal.

Remedy: Just stop. Right-wing news organizations and groups need to blame gun violence on something and it’s easier to blame everything other than gun access. We at Cannabias are not in the business of taking positions on firearm policy but this ‘blame marijuana’ narrative is just as hollow as the ‘blame heavy metal’ narrative that followed Columbine (which happened when cannabis was outlawed in all 50 states) and the ‘blame violent video games’ narrative that always pops up (despite a complete lack of evidence). It’s a red herring and a distraction from the real causes of gun violence, which is almost certainly not cannabis.

End


Rick Steves Dedicates $100K to Midterm Cannabis Legalization Efforts

Rick Steves, travel writer, television host, and cannabis activist, has pledged to spend up to $100,000 to support cannabis legalization efforts around the country in the upcoming mid-term elections, the Regina Leader-Post reports. Steves, who serves as board chair of NORML, announced in a fundraising email he will match donations up to $100,000; he also said he is devoting eight days of campaigning to the legalization cause this election season.

“I’ve spent the last five election seasons campaigning around the country for legalization ballot initiatives[ …] So far, we’ve won in nearly every state we’ve contested. The majority of the American public is with us. We just need to smartly make our point to win at the ballot box. And that takes hard work and money.” – Steves, in the email, via the Leader-Post

Steves, who has campaigned for cannabis legalization in Washington, Oregon, Massachusetts, Maine, and New Jersey, will give away a copy of his book “On the Hippy Trail,” which documents his travels from Istanbul to Kathmandu in 1978 and includes an account of his first time consuming cannabis in Afghanistan, for those who donate over $100.

In the email, Steves reminds readers anti-cannabis groups are “fundraising and spending money in an effort to defeat pro-marijuana ballot initiatives” this fall. He says, “regressive and reactionary forces are working to roll back civil liberties across our country. And I can’t just stand by.”

Maryland, Missouri, South Dakota, North Dakota, and Oklahoma all have adult-use questions on the November ballot, the report says.

End


Food Manufacturing Compliance & Training Experts Partner with Leading Cannabis Law Firm to Launch E-Learning & Compliance Tool Rootwurks

The interactive, customizable Rootwurks platform was built by the founders of Alchemy Systems, now Intertek Alchemy, and features content co-produced and vetted by Vicente Sederberg LLP

Austin, Texas (May 23, 2022) — Rootwurks, Inc. (“Rootwurks”), an e-learning, training, and compliance management platform solution designed by the former founder of an industry-leading food compliance and training company, has launched to help cannabis companies maintain regulatory compliance through interactive education and a user-friendly operational toolkit.

The Rootwurks Learning Experience Platform (LXP) was built by the founders of Alchemy Systems (now Intertek Alchemy), the global leader in frontline workforce training, education, and compliance for the food industry. The platform’s customizable, comprehensive programs were developed with the guidance of national cannabis law firm Vicente Sederberg LLP, which has played a leading role in cannabis policy and regulatory matters since the inception of the regulated cannabis industry.

“At Rootwurks, our goal is to help customers simplify cannabis compliance by ensuring their employees have access to the information required to perform their job when and where they need it,” said Chase Eastman, founder and CEO of Rootwurks. “On the LXP, that journey includes compliance training courses and additional tools like checklists, ‘just in time’ reinforcement modules, assessments, and much more. Using these tools and courses, cannabis businesses can more confidently navigate the complexities of cannabis compliance and create a culture of safety for workers and consumers. The pairing of Vicente Sederberg’s guidance with our centerpiece Rootwurks LXP provides a comprehensive and unquestionably valuable service bundle for cannabis operators.”

The Rootwurks LXP features a series of educational courses and micro-modules covering a range of cannabis compliance and safety issues. The program uses automated, digital tools calibrated to track, analyze, and assess the compliance operations of cannabis companies of all sizes in real-time, so businesses can catch mistakes before they cause damage or before they happen at all.

“With legalization spreading throughout the U.S. and across the globe, there is a growing need for cannabis education, workforce training, and compliance tools,” said Brian Vicente, founding partner of Vicente Sederberg LLP. “Helping cannabis companies maintain compliant, professional operations has been a fundamental part of our work for more than a decade.

We are proud to contribute our knowledge and experience to the Rootwurks platform, which represents the next phase in achieving operational excellence in the legal cannabis space.”

Rootwurks is ready to help cannabis companies achieve compliance, organization, and proper counsel. Click here to learn more about the Rootwurks service platform and schedule a free demonstration.

###

About Rootwurks:
Rootwurks is a cannabis e-learning and compliance management platform built through the know-how of some of the leading experts in food manufacturing compliance and cannabis law. The centerpiece of the company is the Rootwurks Learning Experience Platform (LXP), an online cannabis education and compliance tool that was designed to help companies meet their compliance needs and receive educational guidance to build a culture of safety in their daily operations.

About Vicente Sederberg LLP:
​​Vicente Sederberg LLP is a top-ranked national cannabis law firm with offices in California, Colorado, Florida, Massachusetts, Michigan, New York, New Jersey, and Texas. It has been at the leading edge of cannabis policy for more than a decade, helping public and private sector clients shape, implement, and navigate marijuana and hemp laws and regulations across the U.S. and around the world. VS is ranked a Band 1 cannabis law firm in the Chambers USA 2021 Guide, and it was named “Cannabis Law – Law Firm of the Year” at the Chambers USA Awards 2021. For more information, visit https://vicentesederberg.com.

 

End


Green Goddess Supply Eyes Growth via SEC Reg CF Securities Offering

The Cannabis Technology Brand is Raising Funds to Grow and Expand Product Offerings, Market Share and Brand Awareness

HOPEDALE, MA (MAY 16, 2022) – Today, Green Goddess Supply announced the launch of their SEC-approved Regulation Crowdfunding raise (aka “Reg CF”) on the StartEngine.com platform. The Massachusetts-based business empowers anyone to grow their own legal herbs at home themselves, quickly, easily, discreetly, and inexpensively.

Unlike typical start-ups, the company has been around a few years. Initially funded by management and “friends and family,” Green Goddess Supply has built an impressive catalog of cannabis-centric accessory products including storage boxes, rolling trays, grinders, pipes and more. The crown jewel in its product line is the critically acclaimed, award-winning personal home grow system sold and marketed as “The Armoire.” Now, with U.S. patent in-hand and rave reviews, the company believes The Armoire is ready for prime time.

“We are incredibly excited to launch this initiative,” said Founder and CEO, Eric Robichaud. He continued, “What’s impressive to me is management’s ability to build, ship and deliver almost 600 systems during the global pandemic that has been riddled with supply chain obstacles and seemingly never ending “red tape” including, but not limited to, price gouging for Ocean Freight, new hidden costs such as “port congestion,” scarce and expensive domestic LTL shipping, supply chain and materials delays, and more.” The company has overcome these obstacles and is expanding The Armoire product line with new, higher-margin models ready for the 2022 holiday selling season. This capital raise will enable the company to continue to expand the product line, and scale sales and marketing.

Robichaud points out that The Armoire isn’t “just some idea” – it’s gone through R&D, prototyping, pre-production and into production. The company has built-out shipping and warehousing capabilities, internal and external systems and processes, and more. “It’s amazing to see the results of these Armoire units successfully deployed in homes across the country, which have been able to really help to change and improve lives! We’re now ready to scale up and bring it to the masses,” he said.

With this offering, the company will gain access to over 750,000 investors via the StartEngine Regulation CF platform, to showcase their unique, patented cannabis home grow system.

“We are part of a larger, DISRUPTIVE revolution: investing in private companies in red-hot sectors before they go public or are sold,” said Vincent Bitetti, inventor of The Armoire and Chief Cannabis Officer at Green Goddess Supply. “Under Reg CF, companies apply via a highly-regulated system, akin to going public. It all takes place through an SEC-registered intermediary, either a broker-dealer or a funding portal such as StartEngine.com.” These rules are relatively new—the SEC approved Reg CF in 2017. For the first time ever, this enables eligible companies to offer and sell securities through crowdfunding. And similarly, it allows individual investors to access pre-IPO businesses that were previously only accessible to accredited investors – typically via private placements as companies prepare to go public.

The Regulation Crowdfunding campaign is being hosted on the StartEngine.com platform. Interested parties can search “Green Goddess Supply” on StartEngine.com or follow this link directly to the campaign page: https://www.startengine.com/green-goddess. There are special incentives, such as free bonus shares, for investors who commit early in the campaign.

ABOUT GREEN GODDESS SUPPLY
Green Goddess Supply is a “cultivation to consumption” cannabis technology lifestyle brand offering a line of high-quality products to grow, store, prep and consume hemp flower and cannabis products. The company sells direct to consumers at MSRP through its website, and also offers wholesale and distributor accounts to brick and mortar storefronts and industry distributors. Green Goddess Supply strives to exceed expectations and delight customers with quality products and amazing customer service. The Armoire is a trademark of Green Goddess Supply. Green Goddess Supply is a privately held company headquartered in Hopedale, MA with additional warehousing and distribution partners in Los Angeles, CA; Long Island City, NY and Pooler, GA. For more information about the Green Goddess Supply offering, visit the StartEngine website at https://www.StartEngine.com/green-goddess

INVESTOR RELATIONS
617 765-2334 x100
IR@GreenGoddessSupply.com
@greengoddesssupply on Instagram and Facebook

End


Vermont House Imposes 60% THC Cap on Concentrates

The Vermont House last week approved several bills aimed at setting up the state’s adult-use market, including a bill to impose a 60% THC cap on concentrates, VT Digger reports. The amendment, tacked on by state Rep. John Gannon (D), led to frustration from some lawmakers and followed a Department of Health decision to eliminate – and then reimpose – their proposed 60% THC cap.

James Pepper, chair of the Cannabis Control Board, said a 60% THC cap on concentrates would give “the illicit market a monopoly on supplying the demand for these products.”

“There is a very broad consensus among regulators that caps are a bad idea. A black market will fill this gap. They’ll do so using very dangerous products.” – Pepper to VT Digger

State Sen. Dick Sears (D) pointed out that nearby Massachusetts doesn’t have a THC cap and that he would like to see an investigation by the Cannabis Control Board on the impact of the cap on unregulated and out-of-state sales, were it to be included in the law.

The state Department of Health initially sought THC caps but last month David Englander, the agency’s senior policy and legal advisor, wrote a message to Chair of the House Committee on Human Services Rep. Ann Pugh (D) backing eliminating the cap, saying producers would have to use diluting additives to remain under the threshold; however, a day later, Englander sent another message to Pugh, saying the department instead backed the cap.

“The risk to users of high levels of THC are significant and we should not risk contributing to the known risks to consumers’ physical and mental health,” Englander said in his second email. “My communication of yesterday to you was based on incomplete information. All errors are mine and please accept my apologies to you and the committee.”

The Health Department has not commented on the reversal.

The Vermont Senate has moved to a conference committee to reconcile the differences between the House and Senate versions of the bills. Adult-use cannabis sales are expected to commence in October.

End


Connecticut’s Quasi-Public Venture Capital Arm Invests in Cannabis Company

Connecticut Innovations, the state’s quasi-public venture capital arm, has invested $1.25 million in 1906, a Colorado adult-use cannabis company that is moving to the Constitution State, the Hartford Business Journal reports. The investment is reportedly the first investment made by a state entity into a cannabis business.

1906 CEO Peter Barsoom called the investment, which closed in February, “a major milestone for the cannabis industry.”

“…Institutional investors don’t need to wait on the sidelines for changes to federal laws before they participate in the cannabis market.” – Barsoom to the Journal

1906 produces pills comprised of plant-based medicines and low doses of THC and CBD. The company currently has six different variations of the product at dispensaries in Arizona, Colorado, Illinois, Massachusetts, and Oklahoma, the report says.

Connecticut lawmakers approved cannabis reforms last June but sales have not yet commenced. Commissioner for the Department of Consumer Protection Michelle Seagull said in September that while officials had expected adult-use sales to start by the end of this year, the timeline may be delayed.

Officials from Connecticut Innovations said they decided to invest in 1906 because of the company’s leadership in the cannabis space, its strong revenue growth, and support of social justice initiatives. The firm also saw investments from Arcview and Merida in the funding round, the report says. 1906 also plans to use the funds to scale up its employee count and presence in the state.

Connecticut Innovations Vice President of Marketing Lauren Carmody said the “investment will help accelerate the company’s ambitious plans for growth and establish 1906 as the first of many cannabis industry leaders based here in Connecticut.”

End


! Front New

Trusted Cannabis Business Intelligence

Latest Cannabis Industry News

The Ganjapreneur Podcast

Tara Rosenblum: Reporting on New York’s Cannabis Licensing Quagmire

This episode of The Ganjapreneur Podcast features Tara Rosenblum, an investigative reporter for News 12, who has recently released a compelling documentary titled “Cannabis Contest.” The documentary offers an in-depth look at the social equity aspects of cannabis licensing in New York City, showcasing the challenges and triumphs of hopeful licensees within the evolving legal… Read More

Business Announcements

Need help with your cannabis business?

Industry Events


Get the daily briefing

Brief news coverage of the top stories affecting cannabis business owners and entrepreneurs, as well as in-depth analysis and advice for running your company. Join our community of more than 40,000 cannabis professionals and get daily insights designed to help you grow your business.

Business Advice From Our Partners


Cannabis Vocabulary

View all cannabis slang terms >>

Create a profile View all categories

Featured cannabis industry quote:

“Whether bear market or otherwise, I expect that as cannabis matures as an industry, it will increasingly leverage debt as a way to fuel growth and operate business.”

Adam Stettner, CEO – FundCanna

CNN Report Misleads Readers by Failing to Provide Context for Cannabis Use Disorder

In a March 19 story, “Study raises questions about the risk of using medical marijuana for mood and anxiety disorders,” CNN spends the bulk of the article outlining the alleged risks of cannabis use disorder and the supposed dangers of medical cannabis use by patients with mood and anxiety disorders uncovered by researchers at the Harvard Medical School/Massachusetts General Hospital with the Center for Addiction Medicine. But the report buries a key finding: those who participated in the study experienced “greater well-being” and “improvement in insomnia.”

Presence of bias:

Structural bias occurs in two ways: when the organization itself is bias toward a topic or issue or when the story is set up in a way that buries other important facts. The latter is especially harmful since 60% of people who share a story on social media do so without reading past the headline, according to a 2019 Columbia University study. We can extrapolate from the study that the same percentage probably doesn’t even read the whole article themselves and their opinions are based on just the headline. We at Ganjapreneur see it in our social media comments, too – too often someone comments with a question that is actually addressed in the story.

The study CNN reports on followed 269 adults from the Boston area with an average age of 37 who wanted to obtain medical cannabis cards, the participants were divided into two groups: one of which was allowed to get the cards immediately and begin using medical cannabis while the other group served as a control and waited 12 weeks before obtaining cards.

“All participants were able to choose their choice and dose of cannabis products from a dispensary as well as frequency of use. They could also continue their usual medical or psychiatric care. People who obtained cards immediately were twice as likely to develop cannabis use disorder, the study found. Ten percent had developed the disorder by week 12, and that figure rose to 20% if they were using marijuana for anxiety or depression.” – CNN, “Study raises questions about the risk of using medical marijuana for mood and anxiety disorders,” Mar. 19, 2022

Okay, now that sounds pretty damning but let’s provide some context since CNN isn’t defining their terms here. The DSM-5 outlines cannabis use disorder as requiring: “Use of cannabis for at least a one-year period, with the presence of at least two of the following symptoms, accompanied by significant impairment of functioning and distress.

There are 10 other qualifying symptoms associated with the disorder:

  • Difficulty containing use of cannabis- the drug is used in larger amounts and over a longer period than intended.
  • Repeated failed efforts to discontinue or reduce the amount of cannabis that is used
  • An inordinate amount of time is occupied acquiring, using, or recovering from the effects of cannabis.
  • Cravings or desires to use cannabis. This can include intrusive thoughts and images, and dreams about cannabis, or olfactory perceptions of the smell of cannabis, due to preoccupation with cannabis.
  • Continued use of cannabis despite adverse consequences from its use, such as criminal charges, ultimatums of abandonment from spouse/partner/friends, and poor productivity.
  • Other important activities in life, such as work, school, hygiene, and responsibility to family and friends are superseded by the desire to use cannabis.
    Cannabis is used in contexts that are potentially dangerous, such as operating a motor vehicle.
  • Use of cannabis continues despite awareness of physical or psychological problems attributed to use- e.g., anergia, amotivation, chronic cough.
    Tolerance to Cannabis, as defined by progressively larger amounts of cannabis are needed to obtain the psychoactive effect experienced when use first commenced, or, noticeably reduced effect of use of the same amount of cannabis
  • Withdrawal, defined as the typical withdrawal syndrome associate with cannabis, or cannabis or a similar substance is used to prevent withdrawal symptoms.

What CNN fails to provide is the context for the diagnosis of cannabis use disorder in the cohort – and let’s be real here, some of these are completely subjective. Dreams about cannabis? Does that mean I have a grief disorder because I often dream about my dead cat? Tolerance? That’s going to happen with any substance – I have a tolerance to caffeine, does that mean I have a caffeine use disorder?

Look, I’m not trying to go on a diatribe here about cannabis use disorder, I am not a physician and I’m not trying to play one, but CNN should have dug deeper into what symptoms the study participants reported to provide context and avoid context bias.

Adjective bias is also apparent in the report, wherein the second graph contains the word “weed” twice and makes sure to call cannabis use disorder “marijuana use disorder” and the author regularly uses “marijuana” when cannabis would be sufficient.

The accompanying video, which has really nothing to do with the study, also uses the word “pot” despite having an overall positive message pertaining to medical cannabis use. This could be considered photographic bias since the video is an old upload, plugged in just because it has to do with medical cannabis but not the study itself – it doesn’t really offer anything to the narrative.

How to remedy:

Oh, CNN, you’re quickly going to get a broad structural bias label as just about every story authored for your outlet shows some bias toward cannabis. As mentioned above, you would be greatly served by providing context, in this case: what were their alleged symptoms? Perhaps the inclusion of an outside expert would help balance the story as researchers will always back their conclusions even when ‘more research is needed’ as is the case with this study (only including one voice in an article is gatekeeping bias).

Including the non-alarmist parts of the study (improvement in insomnia and greater well-being) in the first or second graph would also help balance this particular article and maybe mentioning that at least 70% of study participants did not meet the criteria for cannabis use disorder would provide some additional balance and context.

So, let me rewrite that headline for you: “Study finds 70% of mood and anxiety disorder patients who receive medical cannabis report no adverse effects.”

End


Open Cannabis Markets Are More Socially Equitable than Markets with a Social Equity Component

In February, I went to a cannabis conference in Albuquerque that blew me away. It wasn’t that the conference was fundamentally different from others I have attended; it was the air of HOPE that permeated the entire expo floor. People were excited. Coming from California, where I haven’t seen this level of excitement, ever — even in the beginning — I started to wonder why New Mexico residents had such a sense of buoyancy. Then I realized it was because they had a reasonable expectation that they would be able to enter the cannabis market if they applied for a license.

This is not the case for most applicants in other legalized states. We applied for licenses in New Mexico in February of this year and in less than two months, the fruits of our labor were realized. On March 15, we received our dispensary and manufacturing licenses less than 45 days after applying. Let me say that again in case you missed it: Less than 45 days after we applied in New Mexico, we received our licenses with a total capital output of $1,000.

There are people in California, Illinois, and Massachusetts who are still waiting for licenses, and those who have licenses who are waiting to realize the potential of their licenses. In New Mexico, there were no particular social equity hoops we had to jump through, no 600-page application (Illinois), no interview requirement (Fresno), no need to have a building (Los Angeles), and no requirement to incubate social equity applicants (Oakland). The truth is that in New Mexico, they did not pit BIPOC, the formerly incarcerated, our nation’s first people, and people harmed by the war on drugs against one another to obtain those licenses. The barriers enacted in social equity states were removed in New Mexico.

New Mexico’s cannabis industry model

New Mexico passed adult-use legalization on April 12, 2021, and in less than a year, the state has licensed more than 500 businesses, outdoor farms, greenhouses, retail outlets, and manufacturing facilities. During the new market’s opening weekend, New Mexico’s retail cannabis sales surpassed $4.5 million dollars. They have made their barriers to entry low and, so far, have no caps on the number of licenses they will issue.

Some may point to Oklahoma, another state that made its barriers to entry low, as a failed attempt at an open market. Although Oklahoma has had issues, they are nothing compared to what we have seen in states that tout themselves as champions of social equity where, despite the headlines, no successful social equity programs actually exist. For example, a friend of mine, who is El Salvadoran, has in hand one of those fabled Los Angeles dispensary licenses that he received during the city’s first lottery. After waiting for months for the local cannabis commission to move forward following a slew of lawsuits, he chose to move to Oklahoma in 2020. He opened his dispensary in less than 90 days and to this day, is very successful. He is still waiting for LA to get its act together, three and a half years after he won that license in the first lottery.

What is the difference between those states and New Mexico? The answer is simple: a limited license market touting a social equity component usually means it is exponentially harder for BIPOC, women, formerly incarcerated-led companies, and anyone not backed by large corporate and/or multi-state operator capital to get a license. An open market with low barriers to entry and little (New Mexico) to no (Oklahoma) social equity demands makes it easier and more cost-effective for BIPOC-, women-, and formerly incarcerated-led companies to get a license.

The problem with social equity

In my opinion, the whole movement around social equity has caused an infantilization of non-white and non-male cannabis entrepreneurs. Social equity applicants have to jump through hoops to prove they have been harmed enough to even be considered for a license. What in The Hunger Games is that? The applications for equity applicants in and of themselves are so complex that the going rate to get them written by lawyers or consultants is $25,000 or more… usually more. That is an entire ancillary industry created off the suffering of people and communities who were harmed by the war on drugs. Let that sink in. Where is the justice in that? The access to capital needed to realize the potential of your license does not exist for BIPOC, women, or the formerly incarcerated. Nor do current capital markets even understand how to assess the creditworthiness of this group of people in lieu of the fact that our financial system is built on a racist foundation designed to intentionally exclude us.

There is no better example than what we see coming out of New York. They announced a $200 million social equity real estate fund in January. In February, they did a state-wide virtual roadshow touting this groundbreaking fund. In March, New York state officials made a bold commitment to ensure the first 100-200 retail licenses go to those formerly incarcerated on cannabis charges and/or their families. Oddly though, they also sent out a request for information asking how to create, administer, and distribute this $200 million social equity fund that same month after announcing it. Do not announce a social equity fund when you don’t know how to create, administer and distribute this type of fund. To truly address the capital needs of the most vulnerable populations from the War on Drugs, New York will need to add much more than a real estate debt fund. They need to add recoverable grants as San Francisco did along with business development support. One, a stand-alone debt facility for real estate isn’t going to get us to an equitable industry. And its not the first, second, or even third step to getting us there.

We have learned that we cannot count on social equity legislation, municipal codes, or programs to help us. What we need and what we should demand now, from the existing regulated states and those to come, is lower barriers to entry. We can look to New Mexico as a roadmap.

End


New Hampshire House Votes to Legalize Cannabis & Put Liquor Commission in Charge

The New Hampshire House of Representatives voted 169-156 last week to legalize cannabis for adult use in the state; however, the bill would create a state-run monopoly system, the Associated Press reports. Under the plan, the state Liquor Commission would regulate the cultivation and sale of cannabis in at least 10 stores.

The vote comes less than three months after the Republican-controlled chamber approved a separate measure that would legalize personal possession and cultivation of cannabis for adults 21-and-older. That bill, which still requires Senate approval, would allow adults to possess up to 3/4 of an ounce of cannabis – which is already decriminalized in New Hampshire – and allow personal cultivation of up to six plants. The proposal passed the lower chamber with a five-vote, veto-proof majority.

During an interview last month with WCVB 5 “On the Record,” Republican Gov. Chris Sununu said that while he doesn’t support broad cannabis legalization, he called the bill approved last week by lawmakers “the way to do” legalization. He indicated that he opposed the reforms because the state had just gotten the opioid crisis under control.

Both of New Hampshire’s border states, Massachusetts and Vermont, have already legalized cannabis for adult use. Sales to adults began in Massachusetts in 2018 while Vermont’s initial bill in 2018 legalized possession and use but not sales – a separate bill to allow sales was passed by Vermont lawmakers in 2020 but sales have yet to commence in the Green Mountain State.

Previous efforts to legalize cannabis in New Hampshire have failed as the House has passed the reforms three times in four years but they have never been approved by the Senate.

End


Reviewing Five of the Top Smell-Proof Bags for Cannabis

When I was in my early 20s I came home from San Francisco for the holidays after being fully immersed in the cannabis culture there for years. One afternoon I took my little cousin shopping, of course packing up my weed in my handbag for a quick toke beforehand. We were walking through the store and she looked at me with laughter in her eyes and commented on the thick smell of pot that was trailing me through the store. It was at this moment when I first realized that I needed a smell-proof bag.

Since that day in 2009, there have been major strides in smell-proof and smell-safe technology. Smell absorbing bags come in every form: Dopp kits, fine leather clutches, duffle bags, and designer roll-top backpacks. These products can help the average cannabis consumer like me, but they can also serve cannabis producers who are forced to navigate murky supply chains.

For this review roundup, Ganjapreneur sourced five of the top smell-proof bags on the market, each with its own unique value.

What does ‘smell-proof’ actually mean?

As it currently stands, there are no standards for what can be marketed as smell-proof, smell-blocking, smell-absorbing, etc. Companies like Rubbermaid which market their containers as air-tight, water-tight, and odor-proof have testing standards to ensure their products meet these criteria. There is no such system in odor-absorbing bag technology and as such, some companies claim to be 100% smell-proof when their bags do actually leak aromas. This can be dangerous for people hoping to mask the scent of cannabis in a prohibition state.

It felt essential to mention that in this review we don’t use a standardized test to gauge the level of odor that escapes the bags listed. But I did use my knowledge and experience to suss through each odor-blocking feature like waterproof zippers, carbon lining, and folding tops to gauge the efficacy of odor absorption based on design. It is best to assume, however, that if you are trying to hide cannabis from trained dogs, relying on a bag alone to protect you isn’t recommended.

Now, check out these bag superlatives, each with individual style and features that set it apart from the crowd.
Jump to a bag: Littlejohn New York | Dime Bags | RYOT | Feel Good Flavors | Rebelle

Best Dressed

Littlejohn New York Wristlet Pouch from the Cache Collection

The Littlejohn collection is built with five-layer “scent-conceal” technology. This technology combines a mesh layer, activated carbon lining, durable protective padding, leather air-tight seams, and sealed rubber zippers. The activated carbon lining is sandwiched between non-woven layers on each side. The mesh layer allows smells to reach the surface area of the carbon liner, the air-tight seams support the carbon absorption, and the site states that the sealed rubber zipper preserves the right balance of moisture. I would add that in my experience the sealed zipper is essential in smell-proof bags. I am confident in saying that this is not only an exceptionally made, fashionable bag– but it’s also smell-proof in the real sense.

I brought the wristlet pouch from the Cache Collection out to do some errands, the design and craftsmanship make it comparable to any designer handbag I’ve owned. Since this is a bag that I’d take out to have a drink or go out with friends, I considered how smell-proof it would be when opening and closing it when being IDed or grabbing the check. Sometimes a bag will block smells until it is opened but then it all wafts out into the open air — when this happened to me once, it wafted into the face of a bouncer in Arizona prior to the state’s legalization reforms, so it’s pretty important to consider this before going out with your loudest herb. The designers at Littlejohn considered this too, and there is a small inner pocket that has its own five-layer technology for cannabis along with an outer pocket that can hold the things you often need. Using the outer pocket for commonly grabbed items can reduce the number of times you need to open the bag, keeping the smells inside while you grab your phone for a quick selfie.

Life of the Party

Dime Bags Omerta Smell Proof Fanny Pack & Combo Lock

Any stoner or festival kid already knows about Dime Bags — the brand is synonymous with padded hemp pipe and bong bags and was one of the first to introduce smell-proof bags to the market. The Omerta Fanny Pack is a multi-compartment, super handy little bag that features water-resistant zippers and a water-resistant polyester exterior. It is lightly padded and has a lock that you can set to your own three-digit code. The main compartment locks by locking the zipper into the mechanism so it can’t be used. The secondary compartment, internal zippered pocket, and secret internal zippered pocket do not lock. It comes in a few colors and the logo is a velcro patch, so you can use one of the customizable patches which add some personal flare.

As the mom of a baby, the fanny pack served as a fantastic way to keep my essentials nearby while baby-wearing. My takeaway: it’s great for someone whose hands are busy. The bag also transported me back to my former life, something I refer to as my 20s. Going to large EDM shows and gatherings and having your hands free but also having your … valuables … on you at all times is essential at these gatherings. The lock really takes all of the nervousness out of dancing your heart out while holding the group’s weed … and stuff.

Most Athletic

RYOT DRY+ Backpack

I can’t even hide my bias, when I pulled this backpack out of the box it immediately became my favorite of the bunch. Don’t misunderstand, I’m going to be rocking that Littlejohn wristlet/crossover bag for a long time, but the DRY+ is something a little extra special. At first, it looks like a bag that a super rad, hardcore bike messenger chick would be wearing in San Francisco in 2009. Is that hyper-specific? Definitely. But it’s also the truth. Each is outfitted with a waterproof, abrasion-resistant outer layer featuring a water bottle pocket and two outer compartments. The top is a roll-and-chinch style closure that is wide for easy loading. Inside, there is a removable SmellSafe carbon bag for an extra layer of protection for escaping odors.

RYOT uses the moniker Smell Proof when referring to their products with the highest level of odor containment and weatherproof protection possible. These products are designed to let no air escape which would mean no smells escape, they also feature SmellSafe Carbon Series technology to reduce the odors that come out when the bag is opened. If someone in the industry needed to transport large amounts of bud I would recommend this product first. I’m also planning to use it during the dry season for bike trips to the grocery store.

Biggest Flirt

Feel Good Flavors Smell-proof Roll Top Bag

The beauty of the LittleJohn and the utility of the RYOT bag converge in the Feel Good Flavors roll-top bag. The outer shell is weatherproof leather and the inside features a carbon thermal lining described by the brand as 100% smell-proof. It features two external pouches closed by waterproof zippers as well as two internal slide pouches and one internal zipped pouch. The bag is also built with gear loops and a code locking roll-top buckle.

Feel Good Flavors lines their bags with carbon technology along with waterproof zippers to control odors. The roll-top is closed by velcro and a lockable buckle that can be set with a personalized three-digit code. This bag offers almost the same aromatic protection as the RYOT but with a less heavy-duty aesthetic, great for someone who wants a larger bag to conceal cannabis odors but isn’t in need of all-weather, intense protection.

Cutest Couple

Rebelle Jerry Bag in Green and Stone from the Rock and Roll Collection

Rebelle is a Massachusetts cannabis dispensary that is growing into a vertical operation in the Berkshires. The Jerry Bag is available both at their dispensary and online. It is marketed as smell-proof and handmade with soft Italian leather in New York. The pouch is sized well to fit into a purse and features a fold-over top and a removable internal pouch.

This bag is cute and convenient, but I wouldn’t regard it as completely smell proof. First, the fold-over completely negates smells-concealing features in the main bag as aromas will escape out of the corners. Secondly, a normal zipper is used for the internal pouch. While the gold zipper is very aesthetically pleasing, it doesn’t conceal smells as well as a rubber zipper. So, while this is cute and fits perfectly into a larger purse for a night out we wouldn’t recommend it for someone trying to completely conceal the smell of their pot.

End


B Real Launches New Dr. Greenthumb’s Flower Line

Cypress Hill frontman B Real has announced a new line of flower coming out under his Dr. Greenthumb brand. Available first in Dr. Greenthumb dispensaries in April, wider distribution is planned for the brand in May across California.

Recognizing consumers’ different price point tolerance, the line is divided into three categories, “loyal,” “legacy,” and “unapologetic.” In addition to each batch of flower passing B Real’s quality test, Dr. Greenthumb flower producers are vetted for their “history, authenticity, and dedication to cannabis culture,” the company said in a press release.

In an email to Ganjapreneur, B Real said he plans to expand the brand in the near future outside of California, possibly starting in Colorado, Michigan, and Massachusetts. He said he wants to deliver what he “would smoke, at the price point it is worth, from a gardener that I would stand behind as a soldier in this war against both prohibitionists and culture suckers looking to appropriate the plant.”

“I have a twofold mission with Dr. Green thumb’s flower. I want to honor the legacy of cannabis by ensuring the original cultivators have a place in the industry and provide accessible, quality cannabis for everyone’s budget.” – B Real in a statement

Dr. Greenthumb partner farms are approved by B Real and his team, who share the approval process via online video through a QR code that comes with each purchase. Strains will change according to each farm’s menu and will be exclusive to the brand. Farms will change regularly, the company said in a press release.

The rapper indicated that a line of concentrates will follow flower in each market and he wanted to assure fans Dr. Greenthumb “remains independent” and everyone should expect to “see the brand in a lot of really cool places, doing some awesome things.”

End


New York Potency Tax Could Drive Prices as High as $70 an Eighth

New York’s adult-use cannabis law includes a potency tax, which, in addition to the state’s sales and local taxes, could drive the price per eighth as high as $70, Syracuse.com reports. The law taxes distributors half a cent per milligram of the amount of total THC for flower, eight-tenths of one cent per milligram for concentrates, and three cents per milligram of THC for edibles.

The state’s sales tax rate is 9% and localities can impose their own taxes as well, which could raise the overall tax rate for flower as high as 30% or as much as 55% for edibles, said tax attorney Jason Klimek, who co-leads the Cannabis Team at law firm Barclay Damon.

By comparison, neighboring Massachusetts has a maximum 20% tax rate which is tied to sales which could put New York at a competitive disadvantage once sales launch. The state is also home to several Native American tribes, some of which have already launched cannabis sales, and carry no taxes.

Kaelan Castetter, founder of business consulting firm Castetter Cannabis Group and co-founder of the New York Cannabis Growers and Processors Association, told Syracuse.com that including a potency tax could also work to squeeze out smaller operators who are not in the financial positions of large multistate operators who would be able to withstand the tax and still offer competitive prices.

“Really, you’re setting up cultivators to be in a position down the line where they’re not able to eke out a profit, and the ones that will are the biggest ones.” – Castetter to Syracuse.com

Lauren Rudick, co-founder of law firm Hiller, PC’s cannabis law practice, said the THC tax could incentivize cultivators and distributors to offer products that are lower in THC but balance other cannabinoids and terpenes to create a better user experience and that it could offer an opportunity for the industry to better educate consumers who may think THC is solely responsible for the experience of a product.

“I see this as a tremendous opportunity for people to become educated on the endocannabinoid system,” she told Syracuse.com. “I think it’s going to spur some really unique product development.”

Ulrik Boesen, director of excise tax policy at The Tax Foundation, an independent tax policy nonprofit, said that the THC tax makes sense from the government’s perspective because, generally, cannabis markets start out hot but sales fall as markets mature and since THC is one of the few commonalities between cannabis products, it seems logical to pin the tax to the molecule.

“It’s really hard for states to forecast revenue if it’s based on the price of a volatile commodity,” he said. “It’s much easier for them to forecast volume.”

New York lawmakers approved adult-use reforms last year but sales are not expected to commence in the state until 2023.

End


Cresco Labs to Acquire Columbia Care in $2B Deal

Cresco Labs has agreed to acquire Columbia Care Inc. in a deal worth $2 billion, making the firm largest multi-state operator in the U.S. with a pro-forma revenue of more than $1.4 billion.

The deal, which still requires regulatory approval, gives the company more than 130 retail stores throughout 18 states – the second largest in the industry and the largest footprint outside of Florida. On a pro-forma basis, Cresco said it expects to have annual revenues in excess of $100 million in eight different states by 2023.

Charles Bachtell, CEO of Cresco Labs, said the “acquisition brings together two of the leading operators in the industry, pairing a leading footprint with proven operational, brand and competitive excellence.”

“The combination is highly complementary and provides unmatched scale, depth, diversification and long-term growth. … [and] accelerates our journey to become the leader in cannabis in a way no other potential transaction could.” – Bachtell in a press release

Nicholas Vita, CEO of Columbia Care described the deal as a “historic moment.”

“With Columbia Care’s strategic national footprint in the most attractive markets and Cresco Labs’ success in execution and incredibly popular brands, we will together create the most important – and the most investable – company in cannabis,” he said in a statement.

The transaction has been unanimously approved by the boards of directors of each of Cresco Labs and Columbia Care.

Independently, the companies currently have the top share positions in four markets – including Illinois, Pennsylvania, Colorado, and Virginia, and a number two share in Massachusetts. The companies also said they have a pathway to a top-three position in New York, New Jersey, and Florida, which bring the combined company to a material market position in seven of the top 10 markets by revenue in 2025, according to cannabis industry analytics firm BDSA’s top-10 largest and fastest-growing markets by 2025, representing approximately 55% of the U.S. population and over 70% of the addressable cannabis market.

The transaction is the second-largest in the history of the U.S. cannabis industry – behind the $2.1 billion takeover of Harvest Health and Recreation by Trulieve Cannabis Corp. in October 2021.

End


New Hampshire Governor Not Ready to Legalize Cannabis

During an interview with WCVB 5 “On the Record” New Hampshire Gov. Chris Sununu (R) said he was still unsure whether the state was ready to legalize cannabis for adult use, although he admitted he likes the bill currently being considered by lawmakers.

Sununu said that he doesn’t think it is the right time to legalize cannabis in the state as officials have just gotten the opioid crisis under control. He noted that New Hampshire is the only state that did not see an increase in opioid-related deaths last year.

“If you’re gonna do it, that’s the way to do it. But I just think we’re seeing – we’re the one state that’s seeing really positive results [from efforts to address the opioid crisis] – we’ve got a long way, of course, I mean almost 400 people died last year [from opioids]. The rest of the country has doubled their opioid deaths, we’re down 18% in the past three years.” – Sununu on “On the Record”

Both of New Hampshire’s border states, Massachusetts and Vermont, have legalized cannabis for adult use. Sales to adults began in Massachusetts in 2018 while Vermont’s initial bill in 2018 legalized possession and use but not sales – a separate bill to allow sales was passed by Vermont lawmakers in 2020 but sales have yet to commence in the Green Mountain State.

New Hampshire lawmakers in 2017 approved a bill to decriminalize possession of up to three-quarters of an ounce of cannabis – which was signed by Sununu – while the state House of Representatives approved a broad legalization bill in January. The passage marked the fourth time in three years the lower chamber has approved the reforms.

End